Bioverativ Shareholders Sue To Block $11.6B Sale To Sanofi
Shareholders of Bioverativ Inc. slapped the biopharmaceutical company and its board of directors with a proposed securities class action in Massachusetts federal court on Thursday, accusing them of withholding crucial information...To view the full article, register now.
Already a subscriber? Click here to view full article